rs149196615

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_017755.6(NSUN2):​c.529C>T​(p.His177Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00061 in 1,604,466 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00045 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00063 ( 2 hom. )

Consequence

NSUN2
NM_017755.6 missense

Scores

1
8
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:1U:7

Conservation

PhyloP100: 7.38

Publications

7 publications found
Variant links:
Genes affected
NSUN2 (HGNC:25994): (NOP2/Sun RNA methyltransferase 2) This gene encodes a methyltransferase that catalyzes the methylation of cytosine to 5-methylcytosine (m5C) at position 34 of intron-containing tRNA(Leu)(CAA) precursors. This modification is necessary to stabilize the anticodon-codon pairing and correctly translate the mRNA. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Mar 2011]
NSUN2 Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal recessive 5
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Dubowitz syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • RASopathy
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.15167111).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000449 (68/151304) while in subpopulation AMR AF = 0.00132 (20/15186). AF 95% confidence interval is 0.000872. There are 0 homozygotes in GnomAd4. There are 37 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NSUN2NM_017755.6 linkc.529C>T p.His177Tyr missense_variant Exon 5 of 19 ENST00000264670.11 NP_060225.4 Q08J23-1
NSUN2NM_001193455.2 linkc.424C>T p.His142Tyr missense_variant Exon 4 of 18 NP_001180384.1 Q08J23-2
NSUN2NR_037947.2 linkn.594C>T non_coding_transcript_exon_variant Exon 5 of 18

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NSUN2ENST00000264670.11 linkc.529C>T p.His177Tyr missense_variant Exon 5 of 19 1 NM_017755.6 ENSP00000264670.6 Q08J23-1
NSUN2ENST00000506139.5 linkc.424C>T p.His142Tyr missense_variant Exon 4 of 18 2 ENSP00000420957.1 Q08J23-2
NSUN2ENST00000504374.5 linkn.529C>T non_coding_transcript_exon_variant Exon 5 of 18 2 ENSP00000421783.1 A0A140T9Y7
NSUN2ENST00000505264.1 linkn.139C>T non_coding_transcript_exon_variant Exon 2 of 4 4

Frequencies

GnomAD3 genomes
AF:
0.000456
AC:
69
AN:
151188
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000974
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00132
Gnomad ASJ
AF:
0.00116
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000501
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.000516
AC:
126
AN:
244390
AF XY:
0.000591
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000612
Gnomad ASJ exome
AF:
0.00202
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000589
Gnomad OTH exome
AF:
0.000667
GnomAD4 exome
AF:
0.000627
AC:
911
AN:
1453162
Hom.:
2
Cov.:
31
AF XY:
0.000624
AC XY:
451
AN XY:
722656
show subpopulations
African (AFR)
AF:
0.0000609
AC:
2
AN:
32850
American (AMR)
AF:
0.000702
AC:
30
AN:
42706
Ashkenazi Jewish (ASJ)
AF:
0.00193
AC:
50
AN:
25954
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39600
South Asian (SAS)
AF:
0.000814
AC:
68
AN:
83586
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53284
Middle Eastern (MID)
AF:
0.000360
AC:
2
AN:
5554
European-Non Finnish (NFE)
AF:
0.000645
AC:
716
AN:
1109608
Other (OTH)
AF:
0.000716
AC:
43
AN:
60020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
44
88
131
175
219
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000449
AC:
68
AN:
151304
Hom.:
0
Cov.:
30
AF XY:
0.000501
AC XY:
37
AN XY:
73868
show subpopulations
African (AFR)
AF:
0.0000971
AC:
4
AN:
41188
American (AMR)
AF:
0.00132
AC:
20
AN:
15186
Ashkenazi Jewish (ASJ)
AF:
0.00116
AC:
4
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4790
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10294
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000501
AC:
34
AN:
67922
Other (OTH)
AF:
0.000475
AC:
1
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000720
Hom.:
0
Bravo
AF:
0.000650
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.000469
AC:
57

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Intellectual disability, autosomal recessive 5 Pathogenic:1Uncertain:2
Nov 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

-
University of Washington Center for Mendelian Genomics, University of Washington
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

not provided Uncertain:3
Feb 13, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 05, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 177 of the NSUN2 protein (p.His177Tyr). This variant is present in population databases (rs149196615, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with NSUN2-related conditions. ClinVar contains an entry for this variant (Variation ID: 129843). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Mar 28, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in an individual with Dubowitz syndrome who was also heterozygous for another variant in NSUN2 (Dyment DA et al., 2021); This variant is associated with the following publications: (PMID: 33098347) -

Inborn genetic diseases Uncertain:1
Jan 08, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.529C>T (p.H177Y) alteration is located in exon 5 (coding exon 5) of the NSUN2 gene. This alteration results from a C to T substitution at nucleotide position 529, causing the histidine (H) at amino acid position 177 to be replaced by a tyrosine (Y). The p.H177Y alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Intellectual disability Uncertain:1
Jan 01, 2019
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.27
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.24
T;.
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.93
D;D
M_CAP
Benign
0.0089
T
MetaRNN
Benign
0.15
T;T
MetaSVM
Benign
-0.74
T
MutationAssessor
Uncertain
2.1
M;.
PhyloP100
7.4
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-3.5
D;D
REVEL
Benign
0.24
Sift
Benign
0.079
T;T
Sift4G
Uncertain
0.056
T;T
Polyphen
0.96
D;.
Vest4
0.65
MVP
0.45
MPC
1.3
ClinPred
0.48
T
GERP RS
5.3
Varity_R
0.64
gMVP
0.63
Mutation Taster
=252/48
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149196615; hg19: chr5-6623335; API